The "viral-metabolic" interaction mechanisms and management challenges in chronic hepatitis B combined with metabolic dysfunction-associated fatty liver disease: from clinical evidence to an integrated multidisciplinary framework.

Authors

Qianqian Zhu, Chengde Su, Qiaoqiao Yao, Ting Yang, Yali Xu, Mingdan Li, Qian Liu, Yawen Luo, Ping Yang

Published in

Frontiers in immunology. Volume 17. Pages 1920121. Epub Aug 20, 2026.

Abstract

The comorbidity of chronic hepatitis B and metabolic dysfunction-associated fatty liver disease involves a bidirectional "virus-metabolism" interaction mechanism, presenting a clinical paradox characterized by improved virological markers alongside an increased risk of hepatocellular carcinoma. Therefore, this article aims to systematically review the interaction mechanisms and regulatory factors between the two conditions, and to propose an integrated "virus-metabolism" dual-axis management framework that includes metabolism-stratified antiviral therapy and synchronous metabolic intervention, so as to provide a theoretical basis for stratified management and behavioral intervention of the comorbidity.

PMID:
42694391
Bibliographic data and abstract were imported from PubMed on 04 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.